Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
17. October 2025
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 92570
Articles 1 - 20 / 1851390
EndoCompass project: research roadmap for endocrine causes and consequences of cancer.
Eur J Endocrinol
Carroll JS, Castinetti F, Follin C, Luque RM, Verrijn Stuart AA, Giwercman A, Grozinsky-Glasberg S, Krausz C, Paschou SA, Peeters R, Pieterman CRC, Romanet P, Jiménez-Vacas JM, van Santen HM, Zibar Tom.
PMID: 41104473 [PubMed - indexed for MEDLINE]
EndoCompass project: research roadmap for pituitary and neuroendocrine tumor endocrinology.
Eur J Endocrinol
Castano JP, Dattani MT, Grozinsky-Glasberg S, Karavitaki N, Pavel ME, Andoniadou C, Alexandraki K, Capatina C, Cerbone M, Ferone D, Gan HW, Hofland J, Hofland LJ, Ibanez-Costa A, Ilie MD, Isidori AM, Korbonits M, Kos-Kud, Maghnie M, Mantovani G, Marazuela M, Raverot G, Scarpa A, Schilbach K, Theodoropoulou M, van Santen HM, Zatelli MC.
PMID: 41104469 [PubMed - indexed for MEDLINE]
RNA Nanoparticles Harboring Radioisotopes or Other Imaging Molecules for Spontaneous Tumor Targeting for Early Cancer Diagnosis.
RNA Nanomed
Binzel DW, Xu C, Binzel K, Ghosh A, Pippin A, Li X, Sechi M, Knopp MV, Kumar K, Guo P.
PMID: 41104418 [PubMed]
Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges.
Drug Des Devel Ther
Wu D, Zeng H, Tan J, Xu Q, Khan FA, Pandupuspitasari NS, Yang S, Huang C.
PMID: 41104396 [PubMed - indexed for MEDLINE]
Therapeutic potential of modified Yukgunja-tang (Liujunzi Decoction, Rikkunshito) as an adjuvant treatment for lung cancer: a systematic review and meta-analysis.
Front Pharmacol
Kang SW, Ha S, Kim KI, Jung HJ, Lee BJ.
PMID: 41104332 [PubMed]
Esophageal Cancer in a Mid-esophageal Diverticulum: A Case Report on Diagnostic Challenges and Treatment Outcomes.
Cureus
Vats G, Chandrashekhara P, Anuj, Bhagavan KR.
PMID: 41104271 [PubMed]
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients.
Hepatobiliary Surg Nutr
Cheung KS, Wan EYF, Zhou J, Lam CLK, Leung WK.
PMID: 41104217 [PubMed]
Neoadjuvant systemic therapy for hepatocellular carcinoma: challenges and opportunities-a narrative review.
Hepatobiliary Surg Nutr
Zhang Y, Yue S, Zhang B, Chen X, Zhang W.
PMID: 41104208 [PubMed]
Habitat imaging with intratumoral radiomics for prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Front Mol Biosci
Ji X, Zhao B, Mao Y, Lv M, Wang Y, Su X, Zhang Z, Wu J, Wang Q.
PMID: 41104168 [PubMed]
Cancer Prevention and Therapy With Nutritional Science: Addressing the Gap in Medical Education and Practice.
MedComm (2020)
Collignon TE, Bishayee A.
PMID: 41104163 [PubMed]
Advancing equity in cancer care: a pilot explanatory mixed methods study of a racially, ethnically, and linguistically concordant model of patient navigation.
J Health Equity
Tom A, Gomez-Acosta C, Henderson V, McDougall J, Mendoza JA, Carosso E, Cohn EB, Barrington WE, Bigelow-Chavez L, Nyame YA, Lion KC.
PMID: 41104107 [PubMed]
Lifestyle Medicine in Cardio-Oncology-Addressing Cardiovascular Risks From the 3Â C's: Cancer, Cancer Therapies, and Conventional Risk Factors.
Am J Lifestyle Med
Perry M, Srivastava SB.
PMID: 41104073 [PubMed - as supplied by publisher]
Label-free fluorescence lifetime imaging for real-time guidance of stereotactic biopsy: A feasibility study in brain cancer patients.
Neurooncol Adv
Alfonso-Garcia A, Bec J, Hassan MA, Noble Anbunesan S, Kraft L, Bobinski M, Jin LW, Lee HS, Harsh GR, Bloch O, Marcu L.
PMID: 41104039 [PubMed]
Correction: Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs. Trastuzumab, Chemotherapy, and Pertuzumab: A Systematic Review and Meta-Analysis of Clinical Trials.
Cureus
Fazal F, Bashir MN, Adil ML, Tanveer U, Ahmed M, Chaudhry TZ, Ijaz AA, Haider M.
PMID: 41104033 [PubMed]
Establishment and validation of a nomogram model for predicting early death in patients with endometrial cancer bone metastases.
Front Oncol
Tang Q, Sun Y, Gao Y.
PMID: 41103962 [PubMed]
A preoperative prediction model for ipsilateral axillary lymph node metastasis of breast cancer based on clinicopathological and ultrasonography features: a prospective cohort study.
Front Oncol
Guo X, Ling Y, Peng Y, Tan Q, Xie Y, Zhao H, Lv Q.
PMID: 41103960 [PubMed]
Early postoperative enteral nutrition and its impact on postoperative recovery in gastrointestinal tumor surgery.
Front Oncol
Weng PH, Du Y, Yuan F.
PMID: 41103959 [PubMed]
Real-world multicenter study of rezvilutamide plus androgen deprivation therapy in Chinese patients with high-volume metastatic hormone-sensitive prostate cancer.
Front Oncol
Peng S, Zhang R, Zou Z, Wei Q, Dai C, Wu J, Ye L, Wei Y, Huang L.
PMID: 41103956 [PubMed]
Traditional medicine, environmental exposures, and cultural practices in cancer risk: insights from low- and middle-income countries.
Front Oncol
Miya TV, Marima R, Marutha T, Luvhengo TE, Mkhize-Kwitshana Z, Chauke-Malinga N, Mazibuko G, Dlamini Z.
PMID: 41103955 [PubMed]
Super-enhancer DNA methylation in cancer: the mechanism of action and therapeutic directions.
Front Oncol
Bi Y, Zou K, Wang K.
PMID: 41103952 [PubMed]
Articles 1 - 20 / 1851390
Page 1 of 92570
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy